Several other analysts have also weighed in on ACB. GMP Securities reissued a hold rating and issued a $9.50 price objective on shares of Aurora Cannabis in a report on Tuesday, February 12th. Seaport Global Securities assumed coverage on Aurora Cannabis in a report on Thursday, February 21st. They set a neutral rating for the company. Finally, Jefferies Financial Group assumed coverage on Aurora Cannabis in a report on Monday, February 25th. They set a buy rating for the company. One research analyst has rated the stock with a hold rating and three have issued a buy rating to the stock. The company has a consensus rating of Buy and a consensus price target of $9.50.
Shares of NYSE:ACB traded down $0.08 during trading on Monday, hitting $8.99. The company’s stock had a trading volume of 56,250,495 shares, compared to its average volume of 29,169,904. The company has a debt-to-equity ratio of 0.08, a quick ratio of 2.50 and a current ratio of 3.31. Aurora Cannabis has a fifty-two week low of $4.05 and a fifty-two week high of $12.52. The stock has a market cap of $8.06 billion, a price-to-earnings ratio of 74.92 and a beta of 2.90.
Aurora Cannabis (NYSE:ACB) last released its quarterly earnings results on Monday, February 11th. The company reported ($0.04) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.06) by $0.02. The business had revenue of $41.00 million for the quarter. Aurora Cannabis had a positive return on equity of 3.95% and a negative net margin of 57.54%. On average, equities research analysts predict that Aurora Cannabis will post -0.17 EPS for the current year.
Several large investors have recently bought and sold shares of the company. Financial Advocates Investment Management bought a new position in Aurora Cannabis in the 4th quarter worth approximately $74,000. Flagship Harbor Advisors LLC bought a new position in Aurora Cannabis in the 4th quarter worth approximately $26,000. Advisory Services Network LLC bought a new position in Aurora Cannabis in the 4th quarter worth approximately $29,000. Trustcore Financial Services LLC bought a new position in Aurora Cannabis in the 4th quarter worth approximately $33,000. Finally, Farmers & Merchants Trust Co of Chambersburg PA bought a new position in Aurora Cannabis in the 4th quarter worth approximately $36,000. 8.16% of the stock is owned by institutional investors.
About Aurora Cannabis
Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.
Receive News & Ratings for Aurora Cannabis Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Aurora Cannabis and related companies with MarketBeat.com’s FREE daily email newsletter.